Tamsulosin hydrochloride (CAS 106463-17-6) Alpha-blocker Pharmaceutical API

Tamsulosin hydrochloride (CAS 106463-17-6) is a highly selective alpha-blocker API, celebrated for its targeted action on the prostate and urinary tract. Its unique molecular structure specifically binds to alpha-1A adrenergic receptors in the prostate gland and bladder neck, relaxing smooth muscle tissue to improve urine flow and reduce urinary symptoms. This high-purity pharmaceutical raw material meets stringent global quality standards, ensuring consistent potency and stability for clinical formulation.

Widely utilized in urological drug development, it is a core ingredient for formulating medications to treat benign prostatic hyperplasia (BPH). Valued for its favorable safety profile and ability to alleviate symptoms like frequent urination, nocturia, and difficulty initiating urination, it addresses critical unmet needs for BPH patients. Choose this trusted alpha-blocker API to develop high-efficacy formulations that enhance urinary function and improve patients’ quality of life.